ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Equasens

Equasens (0R9T)

62.20
0.00
(0.00%)
Closed December 22 11:30AM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
62.20
Bid
0.00
Ask
0.00
Volume
54
0.00 Day's Range 0.00
62.20 52 Week Range 62.20
Market Cap
Previous Close
62.20
Open
-
Last Trade
2
@
43.85
(O)
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
183
Shares Outstanding
15,174,000
Dividend Yield
-
PE Ratio
13.95
Earnings Per Share (EPS)
3.1
Revenue
222.57M
Net Profit
47.05M

About Equasens

Sector
Computer Programming Service
Industry
Computer Programming Service
Headquarters
Nancy, Meurthe-et-moselle, Fra
Founded
-
Equasens is listed in the Computer Programming Service sector of the London Stock Exchange with ticker 0R9T. The last closing price for Equasens was 62.20 €. Over the last year, Equasens shares have traded in a share price range of 62.20 € to 62.20 €.

Equasens currently has 15,174,000 shares outstanding. The market capitalization of Equasens is 943.82 € million. Equasens has a price to earnings ratio (PE ratio) of 13.95.

0R9T Latest News

EQUASENS : Digipharmacie obtient l’immatriculation officielle en tant que Plateforme de Dématérialisation Partenaire (PDP)

EQUASENS : Digipharmacie obtient l’immatriculation officielle en tant que Plateforme de Dématérialisation Partenaire (PDP) Villers-lès-Nancy, le 21 novembre 2024 – 18h00 (CET)COMMUNIQUE DE PRESSE...

EQUASENS : Intelligence artificielle : Equasens et Posos transforment la dispensation pharmaceutique

EQUASENS : Intelligence artificielle : Equasens et Posos transforment la dispensation pharmaceutique Villers-lès-Nancy, le 20 novembre 2024 – 18h00 (CET)COMMUNIQUE DE PRESSE Le Groupe Equasens et...

EQUASENS : Chiffre d’affaires au 30 septembre 2024 à 158,2 M€ - Retour de la croissance sur le T3 (+0,3%)

EQUASENS : Chiffre d’affaires au 30 septembre 2024 à 158,2 M€ - Retour de la croissance sur le T3 (+0,3%) Villers-lès-Nancy, le 7 novembre 2024 - 18h00 (CET) COMMUNIQUE DE PRESSE Chiffre...

Equasens: 2024 nine-month revenue: €158.2 million - Return to growth in Q3 (+0.3%)

Equasens: 2024 nine-month revenue: €158.2 million - Return to growth in Q3 (+0.3%) Villers-lès-Nancy, 7 November 2024 - 6:00 p.m. (CET) PRESS RELEASE 2024 nine-month revenue:...

EQUASENS : Modalités de mise à disposition du rapport financier semestriel 2024

EQUASENS : Modalités de mise à disposition du rapport financier semestriel 2024 Villers-lès-Nancy, le 30 septembre 2024 - 20h00 (CET) COMMUNIQUE DE PRESSE EQUASENS annonce la publication de son...

EQUASENS : Résultats semestriels 2024

EQUASENS : Résultats semestriels 2024 Villers-lès-Nancy, le 27 septembre 2024 - 18h00 (CET) COMMUNIQUE DE PRESSE Résultats semestriels 2024 Une conjoncture économique dégradée et un maintien des...

Equasens: 2024 half-year results

Equasens: 2024 half-year results Villers-lès-Nancy, 27 September 2024 - 6:00 p.m. (CET) PRESS RELEASE 2024 half-year results Group results impacted by weaker economic conditions and continuing...

Equasens: H1 2024 revenue

Equasens: H1 2024 revenue Villers-lès-Nancy, 2 August 2024 - 6:00 p.m. (CET) PRESS RELEASE H1 2024 revenue: €108 million   Contributions from new acquisitions offset the base effect from the...

EQUASENS : Chiffre d’affaires S1 2024

EQUASENS : Chiffre d’affaires S1 2024 Villers-lès-Nancy, le 2 août 2024 - 18h00 (CET) COMMUNIQUE DE PRESSE Chiffre d’affaires S1 2024 à 108 M€ La contribution des croissances externes équilibre...

EQUASENS : BILAN SEMESTRIEL S1-2024 DU CONTRAT DE LIQUIDITE CONTRACTE AVEC LA SOCIETE DE BOURSE GILBERT DUPONT

EQUASENS : BILAN SEMESTRIEL S1-2024 DU CONTRAT DE LIQUIDITE CONTRACTE AVEC LA SOCIETE DE BOURSE GILBERT DUPONT Villers-lès-Nancy, le 05 juillet 2024 - 18h30 (CET) COMMUNIQUE DE PRESSE...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10062.262.262.28762.2DE
40062.262.262.218562.2DE
120062.262.262.218362.2DE
260062.262.262.213362.2DE
520062.262.262.229062.2DE
1560062.262.262.243762.2DE
2600062.262.262.247162.2DE

0R9T - Frequently Asked Questions (FAQ)

What is the current Equasens share price?
The current share price of Equasens is 62.20 €
How many Equasens shares are in issue?
Equasens has 15,174,000 shares in issue
What is the market cap of Equasens?
The market capitalisation of Equasens is EUR 943.82M
What is the 1 year trading range for Equasens share price?
Equasens has traded in the range of 62.20 € to 62.20 € during the past year
What is the PE ratio of Equasens?
The price to earnings ratio of Equasens is 13.95
What is the cash to sales ratio of Equasens?
The cash to sales ratio of Equasens is 2.95
What is the reporting currency for Equasens?
Equasens reports financial results in EUR
What is the latest annual turnover for Equasens?
The latest annual turnover of Equasens is EUR 222.57M
What is the latest annual profit for Equasens?
The latest annual profit of Equasens is EUR 47.05M
What is the registered address of Equasens?
The registered address for Equasens is 5 ALLEE DE SAINT-CLOUDN BP117, NANCY, MEURTHE-ET-MOSELLE, 54600
What is the Equasens website address?
The website address for Equasens is www.equasens.com
Which industry sector does Equasens operate in?
Equasens operates in the COMPUTER PROGRAMMING SERVICE sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TIRTiger Royalties And Investments Plc
0.15p
(50.00%)
3.41M
BAYBay Capital Plc
5.50p
(19.57%)
209.68k
MASTMast Energy Developments Plc
0.19p
(18.75%)
20.09M
MHNMenhaden Resource Efficiency Plc
148.50p
(18.33%)
1M
ZENZenith Energy Ltd.
2.50p
(16.28%)
3.93M
TRYBTribe Technology Plc
0.115p
(-79.09%)
24.27M
NMTNeometals Ltd
2.75p
(-35.29%)
49.4k
SNGSynairgen Plc
2.46p
(-34.31%)
4.31M
TM1Technology Minerals Plc
0.185p
(-26.00%)
174.03M
AYMAnglesey Mining Plc
0.70p
(-17.65%)
2.99M
NTVONativo Resources Plc
0.002p
(5.26%)
971.94M
TRPTower Resources Plc
0.035p
(9.38%)
620.03M
LLOYLloyds Banking Group Plc
54.16p
(-0.26%)
341.48M
ORCPOracle Power Plc
0.0255p
(-1.92%)
192.93M
TM1Technology Minerals Plc
0.185p
(-26.00%)
174.03M

Discussion

View Full Feed
StayHumble StayHumble 5 minutes ago
💹90+Million XPERT .000001 BUYS💹insider BUYBACK Ongoing💹💹 https://ih.advfn.com/stock-market/USOTC/healthier-choices-manage-pk-HCMC/trades
HCMC
StayHumble StayHumble 8 minutes ago
w0w 6Digit .000001 Buys!💹Facts Matter Sometimes 💹💹💹💹
https://ih.advfn.com/stock-market/USOTC/healthier-choices-manage-pk-HCMC/trades
HCMC
Lime Time Lime Time 8 minutes ago
It's going to be a very cold day tomorrow and I guarantee that you won't report on the deaths of a sub zero day
swingingRichard swingingRichard 12 minutes ago
Benny's Basher List. Sounds like fun. How come his $1000/hr lawyer can't seem to get anyone in court?

AABB
alertmeipp alertmeipp 14 minutes ago
ED-235 is probably more valuable to PFE than anyone else. Then, RSV and the patent lawsuit settlement could all bring significant value to Pfizer. As well, PFE is under pressure to replenish its drug pipeline, ENTA's intellectual property and immunology program could provide crucial support in this
ENTA PFE
georgejjl georgejjl 15 minutes ago
The Tesla Model 3 Performance Is The Most American-Built Vehicle

https://www.topspeed.com/most-american-made-car/

Good luck and GOD bless,
TSLA
StayHumble StayHumble 15 minutes ago
w0w Xcellent💹 Kramers 100% Involved💹 Billions NakedSH0rt ?

It explains the situation about shorting and naked shorting perfectly!

Again, this is a MUST WATCH video for anyone who believes in $DBMM (naked or otherwise)!

I'd love to he
DBMM
Guzzi62 Guzzi62 16 minutes ago
Really?

None of my business, but why don't you wait until MHRA make a decision regarding DC-Vax?

I want out as well, but I am waiting for that all important approval that can come anytime now.
NWBO
knrorrel knrorrel 16 minutes ago
$QNCCF definitely keep an eye on it. This stock rose 130% twice in the last week and the week before and was already above 50 cents and has fallen to 26 cents and could now give a big push upwards, $QNCCF is in the quantum area, it is in the AI ??area and has an agreement with IBM and has a dip 
QNCCF
knrorrel knrorrel 18 minutes ago
$QNCCF definitely keep an eye on it. This stock rose 130% twice in the last week and the week before and was already above 50 cents and has fallen to 26 cents and could now give a big push upwards, $QNCCF is in the quantum area, it is in the AI ??area and has an agreement with IBM and has a dip 
QNCCF
fuagf fuagf 21 minutes ago
Guess you know the difference between weather and climate,
and are just pretending you don't. Trump loves pretenders.
knrorrel knrorrel 25 minutes ago
$NVNI could easily see $20 or $30 on Monday, maybe even $50,.....

they will see where $NVNI goes... one could think the same pattern as last week with NUKK $1 to over $77 in 4-5 days

I have my shares and will enjoy this ride.

all only imho !
NUKK NVNI
MiamiGent MiamiGent 27 minutes ago
I like Publix. It's Florida.

I bet that lasts you for the year.
Kam8 Kam8 29 minutes ago

19/20 Dec 2024, CHM Meeting. 🤞🤞
NWBO
fuagf fuagf 30 minutes ago
Hanauer knows what's up. Stands out.

OT First time in life have napped for two hours in afternoon two days
in row. And i thought you sere supposed to feel better after a sleep .
knrorrel knrorrel 30 minutes ago
$NVNI Why did you sell? $NVNI could easily see $20 or $30 on Monday, maybe even $50,.....

they will see where $NVNI goes... one could think the same pattern as last week with NUKK $1 to over $77 in 4-5 days

I have my shares and will enjoy this ride.

all o
NUKK NVNI
fuagf fuagf 33 minutes ago
Looks frail.
nowwhat2 nowwhat2 34 minutes ago
SEASONS' GREETINGS


SEASONS' GREETINGS


https://investorshub.advfn.com/uimage/uploads/2024/12/21/hzybsBTC_121212_21_45d_8PM_SEASON_GRINCH_MAG_CALV_100K.jpg


https://investorshub.advfn.com/uimage/uploads/2024/12/21/sqjwyBTC_121212_2
3331 3331 35 minutes ago
BIEL: Actipatch HUGE hit in Taiwan!
https://www.facebook.com/share/p/19sKtNxcLv/
Pittkid Pittkid 35 minutes ago
Lol...
HMBL
gfp927z gfp927z 36 minutes ago
Thanks for the info. I was wondering if MNMD is using some type of micro-dosing of their LSD? I couldn't find specific info on their website about the dosing levels used, but I assume they aren't putting these patients into full blown LSD trips.

Also, while using a proprietary versi
MNMD
JJ8 JJ8 38 minutes ago
I like this analyst- Parkev Tatevosian- He is a professor. He does financial analysis and sees the likely potential of the stock; he evaluates it objectively. I find him to be reliable, not hyping but using stock's history and performance as guide. I have been following him for about a year now.
IONQ
BDEZ BDEZ 40 minutes ago
For sure Iggy....

Your Recent History

Delayed Upgrade Clock